Drugs / Mel
last change Dec 2025 re-read 2 minutes ago

Mel

Developed for
disease related to hematopoietic stem cell transplant
Investigated by
First Affiliated Hospital Xi'an Jiaotong University

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05814718 Apr 2023 → Dec 2025 disease related to hematopoietic stem cell transplant First Affiliated Hospital Xi'an Jiaotong University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Mel Mel 140mg/m2,-2d” NCT05814718